Global Psoriasis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147487
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 132
  • list Pharmaceuticals and Healthcare

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, itchy, and scaly. Psoriasis varies in severity from small, localized patches to complete body coverage.

Scope of the Report:

This report focuses on the Psoriasis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Psoriasis Drugs is expected to grow at a CAGR of roughly 8.9% over the next five years, will reach 20900 million US$ in 2023, from 12600 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

AbbVie

Amgen

Johnson & Johnson

Novartis

Eli Lilly

AstraZeneca

Celgene

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

TNF-inhibitors

Interleukin-inhibitors

Others

Market Segment by Applications, can be divided into

Hospital

Clinic

There are 15 Chapters to deeply display the global Psoriasis Drugs market.

Chapter 1, to describe Psoriasis Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Psoriasis Drugs, with sales, revenue, and price of Psoriasis Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Psoriasis Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Psoriasis Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Psoriasis Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Psoriasis Drugs Introduction

1.2 Market Analysis by Type

1.2.1 TNF-inhibitors

1.2.2 Interleukin-inhibitors

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AbbVie

2.1.1 Business Overview

2.1.2 Psoriasis Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen

2.2.1 Business Overview

2.2.2 Psoriasis Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Johnson & Johnson

2.3.1 Business Overview

2.3.2 Psoriasis Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Johnson & Johnson Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Psoriasis Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Eli Lilly

2.5.1 Business Overview

2.5.2 Psoriasis Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Eli Lilly Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 AstraZeneca

2.6.1 Business Overview

2.6.2 Psoriasis Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 AstraZeneca Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Celgene

2.7.1 Business Overview

2.7.2 Psoriasis Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Celgene Psoriasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Psoriasis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Psoriasis Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Psoriasis Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Psoriasis Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Psoriasis Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Psoriasis Drugs Market Analysis by Regions

4.1 Global Psoriasis Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Psoriasis Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Psoriasis Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Psoriasis Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Psoriasis Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Psoriasis Drugs Sales and Growth Rate (2013-2018)

4.5 South America Psoriasis Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Psoriasis Drugs Sales and Growth Rate (2013-2018)

5 North America Psoriasis Drugs by Countries

5.1 North America Psoriasis Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Psoriasis Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Psoriasis Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Psoriasis Drugs Sales and Growth Rate (2013-2018)

6 Europe Psoriasis Drugs by Countries

6.1 Europe Psoriasis Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Psoriasis Drugs Sales and Growth Rate (2013-2018)

6.3 UK Psoriasis Drugs Sales and Growth Rate (2013-2018)

6.4 France Psoriasis Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Psoriasis Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Psoriasis Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Psoriasis Drugs by Countries

7.1 Asia-Pacific Psoriasis Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Psoriasis Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Psoriasis Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Psoriasis Drugs Sales and Growth Rate (2013-2018)

7.5 India Psoriasis Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Psoriasis Drugs Sales and Growth Rate (2013-2018)

8 South America Psoriasis Drugs by Countries

8.1 South America Psoriasis Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Psoriasis Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Psoriasis Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Psoriasis Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Psoriasis Drugs by Countries

9.1 Middle East and Africa Psoriasis Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Psoriasis Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Psoriasis Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Psoriasis Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Psoriasis Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Psoriasis Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Psoriasis Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Psoriasis Drugs Sales and Growth Rate (2013-2018)

10 Global Psoriasis Drugs Market Segment by Type

10.1 Global Psoriasis Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Psoriasis Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Psoriasis Drugs Revenue and Market Share by Type (2013-2018)

10.2 TNF-inhibitors Sales Growth and Price

10.2.1 Global TNF-inhibitors Sales Growth (2013-2018)

10.2.2 Global TNF-inhibitors Price (2013-2018)

10.3 Interleukin-inhibitors Sales Growth and Price

10.3.1 Global Interleukin-inhibitors Sales Growth (2013-2018)

10.3.2 Global Interleukin-inhibitors Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Psoriasis Drugs Market Segment by Application

11.1 Global Psoriasis Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

12 Psoriasis Drugs Market Forecast (2018-2023)

12.1 Global Psoriasis Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Psoriasis Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Psoriasis Drugs Market Forecast (2018-2023)

12.2.2 Europe Psoriasis Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Psoriasis Drugs Market Forecast (2018-2023)

12.2.4 South America Psoriasis Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Psoriasis Drugs Market Forecast (2018-2023)

12.3 Psoriasis Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Psoriasis Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Psoriasis Drugs Market Share Forecast by Type (2018-2023)

12.4 Psoriasis Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Psoriasis Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Psoriasis Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Psoriasis Drugs Picture

Table Product Specifications of Psoriasis Drugs

Figure Global Sales Market Share of Psoriasis Drugs by Types in 2017

Table Psori

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery